The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ETCTN 10450: A phase I trial of peposertib and lutetium 177 DOTATATE in well-differentiated somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
 
Aman Chauhan
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Crinetics Pharmaceuticals; Ipsen; Lexicon; Seneca Therapeutics; TerSera
Research Funding - Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Merck KGaA (Inst); Nano Therapeutics (Inst); TerSera (Inst)
Travel, Accommodations, Expenses - Entrinsic Health Solutions
 
Jill Kolesar
Stock and Other Ownership Interests - Helix Diagnostics
Consulting or Advisory Role - The Jackson Laboratory
Research Funding - ArtemiLife; Loxo/Lilly (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending for a cell based therapy derived from human macrophages
Travel, Accommodations, Expenses - Caris Life Sciences
 
Donglin Yan
No Relationships to Disclose
 
Daneng Li
Consulting or Advisory Role - Adagene; Delcath Systems; Eisai; Exelixis; Genentech; Ipsen; Merck; MINA THERAPEUTICS; QED Therapeutics; Tersera
Speakers' Bureau - Coherus Biosciences; Eisai; Exelixis; Ipsen; SERVIER; Tersera
Research Funding - AstraZeneca (Inst); Brooklyn ImmunoTherapeutics (Inst)
 
Aman Khurana
No Relationships to Disclose
 
William Edgar Carson
No Relationships to Disclose
 
Susanne M. Arnold
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Exelixis (Inst); Genentech (Inst); Kura Oncology (Inst); LabCorp (Inst); Merck Sharp & Dohme (Inst); National Cancer Institute (Inst); Nektar (Inst); Ohio State University (Inst); Regeneron (Inst); Syneos Health (Inst)
 
Steven Gore
No Relationships to Disclose
 
Larry Rubinstein
No Relationships to Disclose
 
Elise C. Kohn
No Relationships to Disclose
 
Percy Ivy
No Relationships to Disclose
 
Ying Xiao
No Relationships to Disclose
 
Yuni Dewaraja
No Relationships to Disclose
 
Heloisa P. Soares
Consulting or Advisory Role - AstraZeneca; Exelixis; Helsinn Therapeutics; Incyte; Ipsen; Pfizer; TerSera
(OPTIONAL) Uncompensated Relationships - NCCN; North American Neuroendocrine Tumor Society
 
Jan Hendrik Beumer
Employment - Voisin Consulting (I)
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Consulting or Advisory Role - Genentech
Research Funding - Abbvie (Inst); TriSalus Life Sciences (Inst)
Patents, Royalties, Other Intellectual Property - Sulphoraphane for melanoma chemoprevention (Inst)
Expert Testimony - Astellas Pharma; AstraZeneca/Merck; Pfizer; Spectrum Pharmaceuticals; Taiho Pharmaceutical
(OPTIONAL) Uncompensated Relationships - Applied Isotope Technologies; Qrono
 
Bhavana Konda
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Lilly (Inst); Merck (Inst); Xencor (Inst)
 
Vineeth Sukrithan
Consulting or Advisory Role - GE Healthcare
 
Lowell Brian Anthony
No Relationships to Disclose